Mml Investors Services, LLC Bio N Tech Se Transaction History

Mml Investors Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $58,421 - $74,786	-727 Reduced 20.99%	2,736 $220,000
Q1 2024 May 14, 2024	BUY	$88.96 - $112.35 $46,081 - $58,197	518 Added 17.59%	3,463 $319,000
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $267,729 - $332,048	2,945 New	2,945 $311,000
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $411,307 - $646,151	3,473 New	3,473 $522,000
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $283,565 - $615,835	-1,377 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$113.32 - $241.49 $156,041 - $332,531	1,377 New	1,377 $308,000

363

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.